CaliPharms, Inc. (KGET)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jun 12, 2025
CaliPharms Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2013 | FY 2012 | FY 2012 | FY 2011 | FY 2010 | 2005 - 2009 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '14 Sep 30, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Jun '12 Jun 30, 2012 | Jun '11 Jun 30, 2011 | Jun '10 Jun 30, 2010 | 2005 - 2009 |
Cash & Equivalents | 0.02 | - | - | - | 0 | - | Upgrade
|
Cash & Short-Term Investments | 0.02 | - | - | - | 0 | - | Upgrade
|
Other Current Assets | - | - | - | - | 0 | 0 | Upgrade
|
Total Current Assets | 0.02 | - | - | - | 0 | 0 | Upgrade
|
Property, Plant & Equipment | - | - | - | 2 | - | - | Upgrade
|
Long-Term Investments | - | - | - | 1 | 1 | 1 | Upgrade
|
Other Intangible Assets | - | - | - | 1.57 | 1.57 | - | Upgrade
|
Other Long-Term Assets | - | - | - | - | 0.01 | 0.01 | Upgrade
|
Total Assets | 0.02 | - | - | 4.57 | 2.58 | 1.02 | Upgrade
|
Accounts Payable | 1.76 | 1.76 | 1.84 | 3.54 | 2.66 | 0.49 | Upgrade
|
Accrued Expenses | 0.24 | - | - | - | - | - | Upgrade
|
Short-Term Debt | 0.22 | 0.67 | 0.62 | 2.99 | 1.17 | 0.83 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 0.08 | 3.68 | 3.68 | Upgrade
|
Other Current Liabilities | 6.59 | - | - | 2.37 | 9.53 | 9.13 | Upgrade
|
Total Current Liabilities | 8.81 | 2.43 | 2.46 | 8.98 | 17.03 | 14.12 | Upgrade
|
Total Liabilities | 8.81 | 2.43 | 2.46 | 8.98 | 17.03 | 14.12 | Upgrade
|
Common Stock | 0 | 0.1 | 0.02 | 0.01 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 25.15 | 24.63 | 24.46 | 22.67 | 11.62 | 21.54 | Upgrade
|
Retained Earnings | -33.94 | -27.06 | -26.84 | -26.99 | -25.97 | -34.54 | Upgrade
|
Treasury Stock | - | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | Upgrade
|
Total Common Equity | -8.79 | -2.43 | -2.46 | -4.41 | -14.44 | -13.11 | Upgrade
|
Shareholders' Equity | -8.79 | -2.43 | -2.46 | -4.41 | -14.44 | -13.11 | Upgrade
|
Total Liabilities & Equity | 0.02 | - | - | 4.57 | 2.58 | 1.02 | Upgrade
|
Total Debt | 0.22 | 0.67 | 0.62 | 3.07 | 4.85 | 4.51 | Upgrade
|
Net Cash (Debt) | -0.21 | -0.67 | -0.62 | -3.07 | -4.85 | -4.51 | Upgrade
|
Net Cash Per Share | -0.00 | -0.02 | -0.06 | -0.73 | -1.53 | -2.77 | Upgrade
|
Filing Date Shares Outstanding | 4,013 | 3,058 | 18.2 | 8.9 | 3.88 | 1.97 | Upgrade
|
Total Common Shares Outstanding | 3,363 | 96.3 | 18.2 | 8.9 | 3.88 | 1.97 | Upgrade
|
Working Capital | -8.79 | -2.43 | -2.46 | -8.98 | -17.02 | -14.12 | Upgrade
|
Book Value Per Share | -0.00 | -0.03 | -0.13 | -0.50 | -3.72 | -6.64 | Upgrade
|
Tangible Book Value | -8.79 | -2.43 | -2.46 | -5.98 | -16.01 | -13.11 | Upgrade
|
Tangible Book Value Per Share | -0.00 | -0.03 | -0.13 | -0.67 | -4.13 | -6.64 | Upgrade
|
Land | - | - | - | 2 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.